Ganghua Zhang

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Development of a G2/M checkpoint subtype classifier for guiding precision therapy in liver hepatocellular carcinoma patients.

Development of a G2/M checkpoint subtype classifier for guiding precision therapy in liver hepatocellular carcinoma patients.

Journal: Cancer cell international
Published: October 23, 2025

Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy.

Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy.

Journal: Discover oncology
Published: October 04, 2025

SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation.

SRSF10 promotes cisplatin resistance in bladder cancer via BIN1 Exon 12 retention and ANXA1 activation.

Journal: Oncogene
Published: May 16, 2025

Development and validation of a diagnostic machine learning model for gastric cancer risk based on double-negative T cell-related features.

Development and validation of a diagnostic machine learning model for gastric cancer risk based on double-negative T cell-related features.

Journal: Cancer cell international
Published: April 05, 2025

WGX50 attenuates radiation enteritis by targeting ferroptosis and redox homeostasis via EGFR.

WGX50 attenuates radiation enteritis by targeting ferroptosis and redox homeostasis via EGFR.

Journal: Molecular medicine (Cambridge, Mass.)
Published: March 20, 2025

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancer.

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancer.

Journal: Journal of Cancer
Published: June 11, 2024

Multi-omics reveals the impact of cancer-associated fibroblasts on the prognosis and treatment response of adult diffuse highest-grade gliomas.

Multi-omics reveals the impact of cancer-associated fibroblasts on the prognosis and treatment response of adult diffuse highest-grade gliomas.

Journal: Heliyon
Published: February 28, 2024

Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.

Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.

Journal: Cancer cell international
Published: December 26, 2023

WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.

WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.

Journal: Journal of translational medicine
Published: August 25, 2023

ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis.

ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis.

Journal: BMC medical genomics
Published: March 04, 2023

Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma.

Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma.

Journal: Cancer cell international
Published: February 14, 2023

Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas.

Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas.

Journal: Frontiers in oncology
Published: February 02, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026